Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2014 | 09-2008 | 09-2007 | 09-2006 | 09-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,824 | N/A | N/A | N/A | N/A |
| Depreciation Amortization | 23 | N/A | N/A | N/A | N/A |
| Accounts receivable | -55 | N/A | N/A | N/A | N/A |
| Other Working Capital | 303 | N/A | N/A | N/A | N/A |
| Other Operating Activity | -529 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-2,081 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 911 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 4,748 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $5,659 | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -103 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 225 | N/A | N/A | N/A | N/A |
| End Cash Position | 3,700 | N/A | N/A | N/A | N/A |
| Net Cash Flow | $3,475 | $N/A | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,081 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -2,081 | 0 | 0 | 0 | 0 |